Zydus Cadila gets tentative nod from USFDA to market Parkinson's disease drug - ETHealthworld.com

5:32am PDT - August 1st, 2020    health - The Times of India

The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market the capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Zydus Cadila said in a statement.